Clinical trial
Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy
NCT03168815
Study timeline
Study start (actual)2018-01-10Date precision: day
Registry last updated2025-05-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Immunocompromisedunresolved
Hematologic Malignancyunresolved
Post Hematopoietic Stem Cell Transplantunresolved
Hypoxiaunresolved
Pulmonary Infiltratesunresolved
Interventions
Sponsors & collaborators
Mount Sinai Hospital, Canadalead sponsor
Princess Margaret Hospital, Canadacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03168815 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.